AN2 Therapeutics
under reported high unmet medical need disease | AN2 Therapeutics
Company
Deck Type
Sector
Industry
Deck date
February 2025
Slide
18 of 36
Similar slides by AN2 Therapeutics
See diffirences between slides (animation)
Investor Presentation
March 2025
under reported high unmet medical need disease | AN2 Therapeutics
Related slides by other companies
Matinas BioPharma
Investor Presentation
February 2024
high unmet medical need in treatment of invasive aspergillosis | Matinas BioPharma
Matinas BioPharma
Investor Presentation
January 2024
high unmet medical need in treatment of invasive aspergillosis | Matinas BioPharma
Matinas BioPharma
Investor Presentation
March 2024
high unmet medical need in invasive aspergillosis with limited treatment options | Matinas BioPharma
Matinas BioPharma
Investor Presentation
November 2023
high unmet medical need in treatment of invasive aspergillosis | Matinas BioPharma
Other recent decks by AN2 Therapeutics
See all presentations (4 decks)
Investor Presentation
March 2025
Investor Presentation
August 2022
IPO
March 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights